GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseases

FHS
June 4, 2024
7:26 pm

Researchers from the University of Oslo have developed an innovative tool that promises to improve our understanding of heritable human traits and diseases.

Pharmalittle: We’re reading about Amylyx pulling its ALS drug, GLP-1 drugs for Parkinson’s, and more

Top of the morning to you, and a fine one it is. After two days of downpours and strong winds, the Pharmalot campus is now

April 4, 2024

Pharmalittle: We’re watching GLP-1 drug data in Alzheimer’s, a flu shot push for livestock workers, and more

Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I also recently went on a mini-vacation, traveling up to a

July 31, 2024

New Tricuspid Interventions Launched into ‘Broken’ System

NEW YORK CITY — Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce

June 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.